Identification of CpG oligodeoxynucleotide motifs that stimulate nitric oxide and cytokine production in avian macrophage and peripheral blood mononuclear cells

Developmental & Comparative Immunology - Tập 27 - Trang 621-627 - 2003
Haiqi He1, Tawni L. Crippen1, Morgan B. Farnell2, Michael H. Kogut1
1Southern Plains Agricultural Research Center, USDA-ARS, 2881 F & B Road, College Station, TX 77845, USA
2Department of Veterinary Pathobiology, College of Veterinary Medicine, Texas A&M University, College Station, TX 77843, USA,

Tài liệu tham khảo

Janeway, 2002, Innate immune recognition, Annu Rev Immunol, 20, 197, 10.1146/annurev.immunol.20.083001.084359 Krieg, 2002, CpG motifs in bacterial DNA and their immune effects, Annu Rev Immunol, 20, 709, 10.1146/annurev.immunol.20.100301.064842 Bird, 1987, CpG islands as gene markers in the vertebrate nucleus, Trends Genet, 3, 342, 10.1016/0168-9525(87)90294-0 Häcker, 2002, Activation of the immune system by bacterial CpG-DNA, Immunology, 105, 245, 10.1046/j.0019-2805.2001.01350.x Yamamoto, 1992, Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural killer activity, J Immunol, 148, 4072, 10.4049/jimmunol.148.12.4072 Hemmi, 2000, A Toll-like receptor recognizes bacterial DNA, Nature, 408, 740, 10.1038/35047123 Bauer, 2001, Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition, Proc Natl Acad Sci USA, 98, 9237, 10.1073/pnas.161293498 Stacey, 1996, Macrophages ingest and are activated by bacterial DNA, J Immunol, 157, 2116, 10.4049/jimmunol.157.5.2116 Yi, 1996, IFN-γ promotes IL-6 and IgM secretion in response to CpG motifs in bacterial DNA and oigodeoxynucleotides, J Immunol, 156, 558, 10.4049/jimmunol.156.2.558 Chace, 1997, Bacterial DNA-induced NK cell IFN-γ production is dependent on macrophage secretion of IL-12, Clin Immunol Immunopathol, 84, 185, 10.1006/clin.1997.4380 Sun, 1998, Type I interferon-mediated stimulation of T cells by CpG DNA, J Exp Med, 188, 2335, 10.1084/jem.188.12.2335 Jakob, 1999, Bacterial DNA and CpG-containing oligodeoxynucleotides activate cutaneous dendritic cells and induce IL-12 production: implications for the augmentation of Th1 responses, Int Arch Allergy Immunol, 118, 457, 10.1159/000024163 Hartmann, 2000, Delineation of CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo, J Immunol, 164, 1617, 10.4049/jimmunol.164.3.1617 Hartmann, 2000, Mechanism and function of a newly identified CpG DNA motif in human primary B cells, J Immunol, 164, 944, 10.4049/jimmunol.164.2.944 Tascon, 2000, Immunostimulatory bacterial DNA sequences activate dendritic cells and promote priming and differentiation of CD8+ T cells, Immunol, 99, 1, 10.1046/j.1365-2567.2000.00941.x Krug, 2001, Identification of CpG oligonucleotides sequences with high induction of IFN-α/β in plasmacytoid dendritic cells, Eur J Immunol, 31, 2154, 10.1002/1521-4141(200107)31:7<2154::AID-IMMU2154>3.0.CO;2-U Verthelyi, 2001, Human peripheral blood cells differentially recognize and respond to two distinct CpG motifs, J Immunol, 166, 2372, 10.4049/jimmunol.166.4.2372 Ballas, 2001, Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct CpG motifs, J Immunol, 167, 4878, 10.4049/jimmunol.167.9.4878 Kamstrup, 2001, Response of porcine peripheral blood mononuclear cells to CpG-containing oligodeoxynucleotides, Vet Microbiol, 78, 353, 10.1016/S0378-1135(00)00300-X Zhang, 2001, Induction of interleukin-6 and interleukin-12 in bovine B lymphocytes, monocytes and macrophages by a CpG oligodeoxynucleotide (ODN 2059) containing the GTCGTT motif, J Interferon Cytokine Res, 21, 871, 10.1089/107999001753238123 Krieg, 1995, CpG motifs in bacterial DNA trigger direct B-cell activation, Nature, 374, 546, 10.1038/374546a0 Klinman, 1996, CpG motifs expressed by bacterial DNA apidly induce lymphocytes to secrete IL-6, IL-12 and IFNγ, Proc Natl Acad Sci USA, 93, 2879, 10.1073/pnas.93.7.2879 Yi, 1998, CpG oligodeoxynucleotides rescue mature spleen B cells from spontaneous apoptosis and promote cell cycle entry, J Immunol, 160, 5898, 10.4049/jimmunol.160.12.5898 Krieg, 1998, The role of CpG dinucleotides in DNA vaccines, Trends Microbiol, 6, 23, 10.1016/S0966-842X(97)01145-1 Dalpke, 2002, Phosphodiester CpG oligonucleotides as adjuvants: polyguanosine runs enhance cellular uptake and improve immunostimulative activity of phosphodiester CpG oligonucleotides in vitro and in vivo, Immunology, 106, 102, 10.1046/j.1365-2567.2002.01410.x Sester, 2000, Phosphorothioate backbone modification modulates macrophage activation by CpG DNA, J Imunol, 165, 4165, 10.4049/jimmunol.165.8.4165 Hartmann, 1996, Oligodeoxynucleotides enhance lipopolysaccharide-stimulated synthesis of tumor necrosis factor: dependence on Phosphorothioate modification and reversal by heparin, Mol Med, 2, 429, 10.1007/BF03401902 Well, 1998, Age-dependent phagocytosis and bactericidal activities of the chicken heterophil, Del Comp Immunol, 22, 103, 10.1016/S0145-305X(97)00024-4 Krieg, 1998, CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge, J Immunol, 161, 2428, 10.4049/jimmunol.161.5.2428 Klinman, 1999, Repeated administration of synthetic oligodeoxynucleotides expressing CpG motifs provides long-term protection against bacterial infection, Infect Immun, 67, 5658, 10.1128/IAI.67.11.5658-5663.1999 Zimmermann, 1998, CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis, J Immunol, 160, 3627, 10.4049/jimmunol.160.8.3627 Kogut, 1995, In vivo activation of heterophil function in chickens following injection with Salmonella enteritidis-immune lymphokines, J Leukoc Biol, 57, 56, 10.1002/jlb.57.1.56 Gogal, 1997, Analysis of avian lymphocyte proliferation by a new, simple, nonradioactive assay (Lympho-pro), Avian Dis, 41, 714, 10.2307/1592166 Green, 1982, Analysis of nitrate, nitrite and [15N]nitrate in biological fluids, Analyt Biochem, 126, 131, 10.1016/0003-2697(82)90118-X Eisenstein, 2001, Implications of Salmonella-induced nitric oxide (NO) for host defense and vaccines: NO, an antimicrobial, antitumor, immunosuppressive and immunoregulatory molecule, Microbes Infec, 1223, 10.1016/S1286-4579(01)01482-4 MacMicking, 1997, Nitric oxide and macrophage function, Annu Rev Immunol, 15, 323, 10.1146/annurev.immunol.15.1.323 Gao, 1999, Cutting edge: bacterial DNA and LPS act in synergy in inducing nitric oxide production in RAW 264.7 macrophages, J Immunol, 163, 4095, 10.4049/jimmunol.163.8.4095 Ghosh, 2001, Host response to infection: the role of CpG DNA in induction of cyclooxygenase 2 and nitric oxide synthase 2 in murine macrophages, Infect Immun, 69, 7703, 10.1128/IAI.69.12.7703-7710.2001 Utaisincharoen, 2002, CpG ODN activates NO and iNOS production in mouse macrophage cell line (RAW 264.7), Clin Exp Immunol, 128, 467, 10.1046/j.1365-2249.2002.01866.x Nathan, 2000, Reactive oxygen and nitrogen intermediates in the relationship between hosts and microbial pathogens, Proc Natl Acad Sci USA, 97, 8841, 10.1073/pnas.97.16.8841 Djeraba, 2002, Similar pattern of iNOS expression, NO production and cytokine response in genetic and vaccination-aquired resistance to Marek's disease, Vet Immunol Immunopathol, 85, 63, 10.1016/S0165-2427(01)00412-3 Jørgensen, 2001, CpG oligodeoxynucleotides and plasmid DNA stimulate Atlantic salmon (Salmo salar L) leucocytes to produce supernatants with antiviral activity, Dev Comp Immunol, 25, 313, 10.1016/S0145-305X(00)00068-9